The direct inhibition of MCL-1 protein by AZD5991 or indirectly by CDK9 inhibitor (AZD4573), can overcome venetoclax resistance in AML cell lines and PDXs models (79). This evidence concerns the gene MCL1 and acute myeloid leukemia.